Masoumeh Madhi

Masoumeh Madhi

Auto-generated profile, based on publicly available information

Masoumeh Madhi

Immunology Research Center, Faculty of Medicine, Tabriz University of Medical Sciences, Tabriz, Iran

Research Focus & Metrics

Academic Career Length

7Years (2020-Present)

(Calculated once Scilit publication data is synced: current year − year of first publication + 1)

Representative Publications

View All Publications
1 November 2020 in Archives of Clinical Infectious Diseases
Verified
Journal Article
Open access
PDF file
MMMasoumeh Madhi
Masoumeh Madhi
AHAlka Hasani
Alka Hasani
JMJavid Shahbazi Mojarrad
Javid Shahbazi Mojarrad
MRMohammad Ahangarzadeh Rezaee
Mohammad Ahangarzadeh Rezaee
GZGholamreza Zarrini
Gholamreza Zarrini
VSVajihe Sheikhalizadeh
Vajihe Sheikhalizadeh
Background: The emergence of multidrug-resistant (MDR) Pseudomonas aeruginosa and Acinetobacter baumannii is a profound therapeutic concern requiring innovative antimicrobials. Nanotechnology has unlocked new promises, and nanoparticles (NPs) have been used either alone or in combinations against MDR bacteria to overcome antibacterial resistance. Objectives: We aimed to evaluate the antibacterial activity of silver and chitosan nanoparticles alone and in combination with either ciprofloxacin or gentamicin against A. baumannii and P. aeruginosa strains. Methods: The antibacterial activities of synthesized materials were evaluated using microdilution broth, disc diffusion, and drop diffusion methods and the expression of target genes by the quantitative real-time polymerase chain reaction. Results: The result of disc diffusion and drop diffusion methods for chitosan when assessed against MDR or wild type P. aeruginosa and MDR A. baumannii at different concentrations ranged from 8 - 35 mm and 6 - 15 mm respectively, while the range was lower in the nanoparticle form of chitosan. The results also showed that the expression of efflux pump adeB in A. baumannii and mexB in P. aeruginosa decreased after treatment with chitosan, chitosan nanoparticles, and silver nanoparticles; thus, they may be good candidates as efflux pump inhibitors. Conclusions: The present study showed the superiority of antibacterial and anti-efflux pump activity of chitosan over silver nanoparticles against MDR P. aeruginosa and A. baumannii.